Neuroxelin vs P21 — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Neuroxelin is a vendor nootropic peptide blend containing PE-22-28 (10 mg), Pinealon (10 mg), N-Acetyl Semax (20 mg), and N-Acetyl Selank (8 mg), formulated for intranasal administration. It combines four cognitively-active peptides targeting different aspects of brain performanc...
Calculate Neuroxelin dose →P21 is a synthetic peptide derived from ciliary neurotrophic factor (CNTF), designed to promote neurogenesis - the formation of new neurons - in the hippocampus and olfactory bulb. CNTF is a potent neurotrophic factor but has poor CNS penetration and causes significant systemic s...
Calculate P21 dose →| Parameter | Neuroxelin | P21 |
|---|---|---|
| Category | Cognitive & Neurological | Cognitive & Neurological |
| Research | Vendor Blend | Preclinical |
| Half-Life | - | - |
| Typical Dose | - | 100 µg/day |
| Frequency | - | Daily |
| Route | Intranasal | Subcutaneous / Intranasal |
| FDA Status | Not Approved | Not Approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.